CLINICAL_TRIALS
trial_result
· 2017-03-01
Clinical Trial Update: A Study of Tadalafil for Duchenne Muscular Dystrophy [Phase 3]
Summary
Phase 3 trial for tadalafil in Duchenne muscular dystrophy was terminated; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Muscular Dystrophy, Duchenne | Phase 3 | Status: TERMINATED | Results posted: 2017-03-01